Amin Aalipour

Affiliations: 
2015-2019 Bioengineering Stanford University, Palo Alto, CA 
Google:
"Amin Aalipour"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Simonetta F, Lohmeyer JK, Hirai T, et al. (2021) Allogeneic CAR-invariant Natural Killer T Cells Exert Potent Antitumor Effects Through Host CD8 T Cell Cross-Priming. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Robinson ER, Gowrishankar G, D'Souza A, et al. (2021) Minicircles for a two-step blood biomarker and PET imaging early cancer detection strategy. Journal of Controlled Release : Official Journal of the Controlled Release Society
Murty S, Labanieh L, Murty T, et al. (2020) PET reporter gene imaging and ganciclovir-mediated ablation of chimeric antigen receptor T-cells in solid tumors. Cancer Research
Murty S, Haile ST, Beinat C, et al. (2020) Intravital imaging reveals synergistic effect of CAR T-cells and radiation therapy in a preclinical immunocompetent glioblastoma model. Oncoimmunology. 9: 1757360
Shaffer T, Gambhir SS, Aalipour A, et al. (2020) PET imaging of the natural killer cell activation receptor NKp30. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Park SM, Won DD, Lee BJ, et al. (2020) Publisher Correction: A mountable toilet system for personalized health monitoring via the analysis of excreta. Nature Biomedical Engineering
Aalipour A, Le Boeuf F, Tang M, et al. (2020) Viral Delivery of CAR Targets to Solid Tumors Enables Effective Cell Therapy. Molecular Therapy Oncolytics. 17: 232-240
Park SM, Won DD, Lee BJ, et al. (2020) A mountable toilet system for personalized health monitoring via the analysis of excreta. Nature Biomedical Engineering
Aalipour A, Chuang HY, Murty S, et al. (2019) Engineered immune cells as highly sensitive cancer diagnostics. Nature Biotechnology
Simonetta F, Hirai T, Lohmeyer JK, et al. (2019) Allogeneic Chimeric Antigen Receptor-Invariant Natural Killer T Cells Exert Both Direct and Indirect Antitumor Effects through Host CD8 T Cell Cross-Priming Blood. 134: 867-867
See more...